Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
Takeda Pharmaceutical Co Ltd
SWB:TKDA
Price:
16.2
EUR
-1.22%
Market Closed
Market Cap:
€50.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
Recruit Holdings Co Ltd
F:1RH
|
JP |
|
C
|
Consolidated Edison Inc
DUS:EDC
|
US |
|
Mitsubishi HC Capital Inc
F:5B4
|
JP |
|
E
|
Everest Group Ltd
DUS:ERE
|
BM |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKDA's stock price target?
Price Target
18.72
EUR
18.72
EUR
According to Wall Street analysts, the average 1-year price target for 
TKDA is 18.72 EUR with a low forecast of 14.94 EUR and a high forecast of 21.86 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.